Home > Income Statement > MANKIND PHARMA

MANKIND PHARMA
Operating Profit

    Back to Income Statement
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
AD     Remove this Ad

MANKIND PHARMA Last 5 Year Operating Profit History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Operating Profit (Excl OI) ₹2,515 Cr₹190,193 Cr₹1,991 Cr₹165 Cr₹14,447 Cr

What is the latest Operating Profit of MANKIND PHARMA ?

The latest Operating Profit ratio of MANKIND PHARMA is ₹2,515 Cr based on Mar2025 Consolidated results.
Year Operating Profit
Mar2025₹2,515 Cr
Mar2024₹190,193 Cr
Mar2023₹1,991 Cr
Mar2022₹165 Cr
Mar2021₹14,447 Cr

How is Operating Profit of MANKIND PHARMA Trending?

Years Operating Profit % Change
Mar2025 ₹2,515 Cr
-98.68
Mar2024 ₹190,193 Cr
9,454.83
Mar2023 ₹1,991 Cr
1,107.04
Mar2022 ₹165 Cr
-98.86
Mar2021 ₹14,447 Cr -

Compare Operating Profit of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹88,960.5 Cr 5.8% 1.9% -13.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹423,195.0 Cr 3% 9.5% 3.1% Stock Analytics
DIVIS LABORATORIES ₹169,849.0 Cr 1.7% 3.1% 5.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹149,586.0 Cr 4.7% 11.7% 41.1% Stock Analytics
DR REDDYS LABORATORIES ₹109,054.0 Cr 2.1% 6.7% 11.6% Stock Analytics
CIPLA ₹108,703.0 Cr 1.3% 1.3% -9.4% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

5.8%

1.9%

-13.1%

SENSEX

-1.7%

0.5%

8.3%


You may also like the below Video Courses